Malek Chamoun
Corporate Officer/Principal bei SUNSHINE BIOPHARMA, INC.
Vermögen: 222 000 $ am 31.03.2024
Profil
Malek Chamoun is the founder and current President of Nora Pharma, Inc. which is founded in 2017.
He is currently the Chief Development Officer at Sunshine Biopharma, Inc. where he started in 2024.
Mr. Chamoun received his undergraduate degree from Hautes Etudes Commerciales in 2008.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 28.03.2024 | 3 700 000 ( 3,72% ) | 222 000 $ | 31.03.2024 |
Aktive Positionen von Malek Chamoun
| Unternehmen | Position | Beginn |
|---|---|---|
| SUNSHINE BIOPHARMA, INC. | Corporate Officer/Principal | 25.01.2024 |
Nora Pharma, Inc.
 Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Founder | 01.01.2017 |
Ausbildung von Malek Chamoun
| Hautes Etudes Commerciales | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
| Sunshine Biopharma, Inc. | |
Nora Pharma, Inc.
Nora Pharma, Inc. Medical DistributorsDistribution Services Part of Sunshine Biopharma, Inc., Nora Pharma, Inc. is a Canadian company that sells generic drugs. The private company is based in Varennes, Canada. The company was founded in 2017 by Malek Chamoun. Nora Pharma was acquired by Sunshine Biopharma, Inc. on October 20, 2022 for $22.88 million. | Distribution Services |
